Active Pharmaceutical Ingredient (API)
Ledipasvir
Hepatitis C Virus ($\text{HCV}$) $\text{NS5A}$ Inhibitor
A highly potent $\text{NS5A}$ inhibitor used in fixed-dose combination with $\text{Sofosbuvir}$ for the treatment of chronic $\text{HCV}$ infection. $\text{NS5A}$ is a protein essential for $\text{HCV}$ replication and assembly. This combination achieved high cure rates ($\text{SVR}$) for $\text{HCV}$ genotypes 1, 4, 5, and 6.
Technical Profile
- Reference Code
- LED369
- CAS Number
- 1256387-73-0
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Ledipasvir as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| Ledifos H | Cipla Limited | Tablet (90 mg) | ₹15,000.00 | View Details |
| Hepcinat LP H | Natco Pharma Ltd | Tablet (90 mg) | ₹18,500.00 | View Details |